Fnx Performance products are intended strictly for qualified in vitro laboratory research. For Research Use Only. Not for human or animal consumption. Not for compounding or therapeutic application.
Explore mechanism data, evidence tiers, safety, and regulatory context for every compound in the Fnx catalog. Each peptide has its own research profile, filter by category or follow a tag from any product page.
FDA approved with randomized controlled trials behind the approved use.
A large or maturing human RCT base, but not (yet) FDA approved for this use.
Registered and used abroad (e.g. Russia) on modest, mostly single institution trials.
A plausible mechanism, but human efficacy for the marketed use is unproven.
Animal/in vitro data and anecdote only, little to no human evidence and real safety unknowns.
A cell permeable tetrapeptide that binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae and improving bioenergetics, the first drug to directly target mitochondria.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) analog of the pineal peptide epithalamin, studied for telomerase activation and pineal/melatonin rhythm regulation in aging models.
A dinucleotide coenzyme (not a peptide) central to mitochondrial energy, DNA repair, and sirtuin signaling, which declines with age, the basis for the supplementation rationale.
A 16-amino acid peptide encoded by the mitochondrial 12S rRNA gene, discovered as a signaling molecule that activates AMPK to regulate metabolism and insulin sensitivity.